ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
81,808.04
4.25%
S&P 500
5,614.56
-2.70%
Dow Jones
41,911.71
-2.08%
US Dollar vs Yen
147.4455
0.25%
Brent Oil
69.855
1.18%
Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ

  6. Travere Therapeutics Inc (TVTX) 銘柄情報

Travere Therapeutics Inc

Travere Therapeutics Inc (TVTX)

NASDAQ
17.87
-0.22
(-1.22%)
終了 3月11日 5:00AM
15分遅延
18.30
0.43
( 2.41% )
プレマーケット: 7:17PM
15分遅延

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

主要統計と詳細

通貨
18.30
買値
7.19
売値
17.96
出来高
233
0.00 日の範囲 0.00
5.12 52 週間の範囲 25.29
時価総額
1.624B
前日終値
17.87
始値
-
時刻
1
@
17.62
最終取引時間
19:17:41
財務取引量
-
VWAP
-
平均取引量 (3 か月)
1,584,769
発行済株式数
88,739,826
配当利回り
-
PER
-4.93
1 株当たり利益 (EPS)
-3.62
歳入
233.18M
純利益
-321.55M

Travere Therapeutics Inc について

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on the development and commercialization of therapies for people living with rare diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomer... Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on the development and commercialization of therapies for people living with rare diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often lead to end-stage kidney disease. 詳細を表示

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
travere.com
本社
Lewes, Delaware, USA
設立
-
Travere Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker TVTX. The last closing price for Travere Therapeutics was US$17.87. Over the last year, Travere Therapeutics shares have traded in a share price range of US$ 5.12 to US$ 25.29.

Travere Therapeutics currently has 88,739,826 shares in issue. The market capitalisation of Travere Therapeutics is US$1.59 billion. Travere Therapeutics has a price to earnings ratio (PE ratio) of -4.93.

TVTX 最新ニュース

その他のニュース

Form 8-K - Current report
Edgar (US Regulatory)
2025年2月21日
TVTX (-1.22%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
2025年2月13日
TVTX (-1.22%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
2025年2月13日
TVTX (-1.22%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
2025年2月13日
TVTX (-1.22%)
期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-1.28-6.5372829417819.5820.00517.15162536918.76725188CS
4-5.77-23.971749065224.0725.2917.15202179421.62390179CS
120.955.4755043227717.3525.2916.588158476920.24464985CS
265.6244.321766561512.6825.2911.89166538818.13243199CS
529.71113.0384167648.5925.295.12143781013.81918798CS
156-7.49-29.042264443625.7930.355.12126263715.37792556CS
260-6.85-27.236580516925.1533.08995.12110683516.86611622CS

TVTX - Frequently Asked Questions (FAQ)

What is the current Travere Therapeutics share price?
The current share price of Travere Therapeutics is US$ 18.30
How many Travere Therapeutics shares are in issue?
Travere Therapeutics has 88,739,826 shares in issue
What is the market cap of Travere Therapeutics?
The market capitalisation of Travere Therapeutics is USD 1.59B
What is the 1 year trading range for Travere Therapeutics share price?
Travere Therapeutics has traded in the range of US$ 5.12 to US$ 25.29 during the past year
What is the PE ratio of Travere Therapeutics?
The price to earnings ratio of Travere Therapeutics is -4.93
What is the cash to sales ratio of Travere Therapeutics?
The cash to sales ratio of Travere Therapeutics is 6.8
What is the reporting currency for Travere Therapeutics?
Travere Therapeutics reports financial results in USD
What is the latest annual turnover for Travere Therapeutics?
The latest annual turnover of Travere Therapeutics is USD 233.18M
What is the latest annual profit for Travere Therapeutics?
The latest annual profit of Travere Therapeutics is USD -321.55M
What is the registered address of Travere Therapeutics?
The registered address for Travere Therapeutics is 16192 COASTAL HWY, LEWES, DELAWARE, 19958
What is the Travere Therapeutics website address?
The website address for Travere Therapeutics is travere.com
Which industry sector does Travere Therapeutics operate in?
Travere Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
AWHAspira Womans Health Inc
US$ 0.4029
(103.48%)
45.53M
TSVT2seventy bio Inc
US$ 4.94
(76.43%)
408.48k
TNONTenon Medical Inc
US$ 1.93
(54.40%)
8.71M
ADTNADTRAN Holdings Inc
US$ 11.49
(35.34%)
42
REEREE Automotive Ltd
US$ 7.00
(30.35%)
15
MBXMBX Biosciences Inc
US$ 5.01
(-44.21%)
2
JANXJanux Therapeutics Inc
US$ 20.05
(-33.65%)
31
SVRASavara Inc
US$ 2.01
(-24.44%)
4
LZMHLZ Technology Holdings Ltd
US$ 12.01
(-23.31%)
210
SNCRSynchronoss Technologies Inc
US$ 6.01
(-22.45%)
3
AWHAspira Womans Health Inc
US$ 0.4029
(103.48%)
45.53M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 7.85
(6.37%)
16.91M
BTOGBit Origin Ltd
US$ 0.5129
(7.96%)
13.24M
CUTRCutera Inc
US$ 0.1451
(12.92%)
9.56M
TNONTenon Medical Inc
US$ 1.93
(54.40%)
8.71M

TVTX Discussion

投稿を表示

最近閲覧した銘柄

NASDAQ
TVTX
Travere Therapeutics
COIN
TELEUR
Telcoin
COIN
TLNETH
Trustlines Network Token
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2025 ADVFN PLC - 全著作権所有

広告を削除する

サインアップして広告なしのエクスペリエンスを体験してください

広告なし

今すぐ試してください

広告を残す